semaglutide side effect lawyer in michigan Ozempic Vision Lawsuit Semaglutide Discontinuation and Its Health

Half of the participants using semaglutide lost 15% of their body weight, and nearly a third lost 20%

This has led to the development and investigation of several incretin-related therapies such as unimolecular GLP-1/glucagon receptor dual agonists, GLP-1/gastric inhibitory polypeptide (GIP) dual agonists and GLP-1/GIP/glucagon receptor triple agonists

doi: 10.3389/fcell.2022.1079920 153 MaegawaSLuYTaharaTLeeJTMadzoJLiangSet al

This 6-week period begins from the moment the pen is first used for injection, not from when the protective cap is removed or the pen is taken out of refrigerated storage

Many patients taking Ozempic are working towards weight reduction as part of their diabetes management or cardiovascular risk reduction strategy